InsiderTrades

Form 4 for GILD Gilead Sciences

Accepted 2026-03-12 00:00:00 ET · period of report 2026-03-10 · accession 0001782135-26-000010 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2026-03-12 2026-03-10 GILD Mercier Johanna Chief Comm, Corp Aff Off M - OptEx — +6,617 138.0K +5% —
D 2026-03-12 2026-03-10 GILD Mercier Johanna Chief Comm, Corp Aff Off F - Tax $148.56 -3,216 134.8K -2% -$477.8K
DM 2026-03-12 2026-03-10 GILD Mercier Johanna Chief Comm, Corp Aff Off A - Grant $0.00 +45.5K 35.9K New $0
D 2026-03-12 2026-03-10 GILD Mercier Johanna Chief Comm, Corp Aff Off M - OptEx — -6,617 21.1K -24% —

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2026-03-10 M A 6,617 — 137,995 D — — (F1) Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
2 Common Common Stock 2026-03-10 F D 3,216 $148.56 134,779 D — —
3 Derivative Restricted Stock Unit 2026-03-10 A A 9,590 — 30,647 D — · — to — 9,590 Common Stock (F1) Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. (F2) The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.
4 Derivative Restricted Stock Unit 2026-03-10 M D 6,617 — 21,057 D — · — to — 6,617 Common Stock (F1) Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. (F2) The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.
5 Derivative Non-qualified Stock Option (Right to Buy) 2026-03-10 A A 35,880 $0.00 35,880 D $148.56 · — to 2036-03-10 35,880 Common Stock (F3) The stock options have a four-year vesting schedule. 25% vest on the first anniversary date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.